FEATURES OF THE COURSE OF CHRONIC RHINOSINUSITIS AGAINST THE BACKGROUND OF COVID-19
Abstract
Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the upper respiratory tract with a wide range of clinical variants. As our understanding of the pathophysiology of the disease develops, so does our philosophy regarding the approach and treatment of CRS. Endotyping gains an advantage over phenotype-based classifications due to its potential to predict disease severity and provide accurate treatment. Endotyping is particularly useful in complex cases of CRS with a nasal polyp, for which new treatment options such as biologics are now available. The latest European position paper on rhinosinusitis and nasal polyps (EPOS2020) reflects these developments with updated rhinosinusitis classifications and new integrated care schemes.
Keywords
Chronic rhinosinusitis, nasal, mucosaHow to Cite
References
Blanco C. H. et al. Management of complicated pediatric rhinosinusitis in the COVID-19 era //American Journal of Otolaryngology. – 2020. – Т. 41. – №. 6. – С. 102746.
Dokania V. et al. Emergence of invasive fungal rhinosinusitis in recently recovered COVID-19 patients //Annals of Otology, Rhinology & Laryngology. – 2022. – Т. 131. – №. 11. – С. 1202-1209.
Förster-Ruhrmann U. et al. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab //Journal of Allergy and Clinical Immunology. – 2020. – Т. 146. – №. 1. – С. 218-220. e2.
Ismaiel W. F. et al. The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis //American journal of otolaryngology. – 2021. – Т. 42. – №. 6. – С. 103080.
Klimek L. et al. Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper //Allergy. – 2021. – Т. 76. – №. 3. – С. 677-688.
Lee S. W. et al. Estimating COVID-19 infection and severity risks in patients with chronic rhinosinusitis: a Korean nationwide cohort study //The Journal of Allergy and Clinical Immunology: In Practice. – 2021. – Т. 9. – №. 6. – С. 2262-2271. e2.
Marin C. et al. ACE2 downregulation in olfactory mucosa: Eosinophilic rhinosinusitis as COVID‐19 protective factor? //Allergy. – 2021.
Miller L. E., Bhattacharyya N. Antibiotic prescribing for acute rhinosinusitis: In‐person versus virtual visits during Covid‐19 //The Laryngoscope. – 2021. – Т. 131. – №. 7. – С. E2121-E2124.
Morisada M. V. et al. Telemedicine, patient satisfaction, and chronic rhinosinusitis care in the era of COVID-19 //American Journal of Rhinology & Allergy. – 2021. – Т. 35. – №. 4. – С. 494-499.
Saheb Sharif‐Askari F. et al. Are patients with chronic rhinosinusitis with nasal polyps at a decreased risk of COVID‐19 infection? //International forum of allergy & rhinology. – 2020. – Т. 10. – №. 10. – С. 1182-1185.
Tabarsi P. et al. Case report: COVID-19-associated rhinosinusitis mucormycosis caused by Rhizopus arrhizus: a rare but potentially fatal infection occurring after treatment with corticosteroids //The American Journal of Tropical Medicine and Hygiene. – 2021. – Т. 105. – №. 2. – С. 449.
Wang H. et al. The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19 //The Journal of Allergy and Clinical Immunology: In Practice. – 2020. – Т. 8. – №. 10. – С. 3597-3599. e2.
Workman A. D., Bhattacharyya N. Do Patients With Chronic Rhinosinusitis Exhibit Elevated Rates of Covid‐19 Infection? //The Laryngoscope. – 2022. – Т. 132. – №. 2. – С. 257-258.
Xu X. et al. Highlights in the advances of chronic rhinosinusitis //Allergy. – 2021. – Т. 76. – №. 11. – С. 3349-3358.
License
Copyright (c) 2023 S. S. Ortikov, B. A. Khaidarov, E. Sh. Bolieva
This work is licensed under a Creative Commons Attribution 4.0 International License.
